These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

683 related items for PubMed ID: 12182909

  • 1. Absence of paradoxical thrombin activation by fibrin-specific thrombolytics in acute myocardial infarction: comparison of single-bolus tenecteplase and front-loaded alteplase.
    Szabo S, Letsch R, Ehlers R, Walter T, Kazmaier S, Helber U, Hoffmeister HM.
    Thromb Res; 2002 Apr 15; 106(2):113-9. PubMed ID: 12182909
    [Abstract] [Full Text] [Related]

  • 2. Fibrin specificity and procoagulant effect related to the kallikrein-contact phase system and to plasmin generation with double-bolus reteplase and front-loaded alteplase thrombolysis in acute myocardial infarction.
    Hoffmeister HM, Kastner C, Szabo S, Beyer ME, Helber U, Kazmaier S, Baumbach A, Wendel HP, Heller W.
    Am J Cardiol; 2000 Aug 01; 86(3):263-8. PubMed ID: 10922430
    [Abstract] [Full Text] [Related]

  • 3. Microparticle-linked tissue factor activity and increased thrombin activity play a potential role in fibrinolysis failure in ST-segment elevation myocardial infarction.
    Huisse MG, Ajzenberg N, Feldman L, Guillin MC, Steg PG.
    Thromb Haemost; 2009 Apr 01; 101(4):734-40. PubMed ID: 19350119
    [Abstract] [Full Text] [Related]

  • 4. Specific types of activated Factor XII increase following thrombolytic therapy with tenecteplase.
    Pönitz V, Pritchard D, Grundt H, Nilsen DW.
    J Thromb Thrombolysis; 2006 Dec 01; 22(3):199-203. PubMed ID: 17111198
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Thrombolytic therapy in acute myocardial infarction: comparison of procoagulant effects of streptokinase and alteplase regimens with focus on the kallikrein system and plasmin.
    Hoffmeister HM, Szabo S, Kastner C, Beyer ME, Helber U, Kazmaier S, Wendel HP, Heller W, Seipel L.
    Circulation; 1998 Dec 08; 98(23):2527-33. PubMed ID: 9843458
    [Abstract] [Full Text] [Related]

  • 7. Reactive coagulation induced by plasmin in patients treated with recombinant tissue-type plasminogen activator.
    Gram J, Munkvad S, Leebeek FW, Kluft C, Jespersen J.
    Coron Artery Dis; 1993 Apr 08; 4(4):371-7. PubMed ID: 8261210
    [Abstract] [Full Text] [Related]

  • 8. Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism. The Coagulation Project Investigators of the Bolus Alteplase Pulmonary Embolism Group.
    Agnelli G, Iorio A, Parise P, Goldhaber SZ, Levine MN.
    Blood Coagul Fibrinolysis; 1997 Jun 08; 8(4):216-22. PubMed ID: 9199818
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators.
    Cannon CP, Gibson CM, McCabe CH, Adgey AA, Schweiger MJ, Sequeira RF, Grollier G, Giugliano RP, Frey M, Mueller HS, Steingart RM, Weaver WD, Van de Werf F, Braunwald E.
    Circulation; 1997 Jun 08; 98(25):2805-14. PubMed ID: 9860780
    [Abstract] [Full Text] [Related]

  • 11. Procoagulant effects of thrombolytic therapy in acute myocardial infarction.
    Wang Y, Liu Q, Zhu J, Yuan Z, Ma X.
    Chin Med Sci J; 2002 Mar 08; 17(1):36-9. PubMed ID: 12894883
    [Abstract] [Full Text] [Related]

  • 12. [The absence of a procoagulant effect after TNK-t-PA: a comparison with streptokinase and rt-PA].
    De Marco E, Andreotti F, van de Greef W, Quaranta G, Biasucci LM, Kol A, Maseri A, Rebuzzi AG.
    Cardiologia; 1998 Nov 08; 43(11):1209-13. PubMed ID: 9922587
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Real-time measurement of lysis of mural platelet deposits by fibrinolytic agents under arterial flow.
    Graham DA, Huang TC, Keyt BA, Alevriadou BR.
    Ann Biomed Eng; 1998 Nov 08; 26(4):712-24. PubMed ID: 9662163
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA.
    Van de Werf F, Barron HV, Armstrong PW, Granger CB, Berioli S, Barbash G, Pehrsson K, Verheugt FW, Meyer J, Betriu A, Califf RM, Li X, Fox NL, ASSENT-2 Investigators. Assessment of the Safety and Efficacy of a New Thrombolytic.
    Eur Heart J; 2001 Dec 08; 22(24):2253-61. PubMed ID: 11728145
    [Abstract] [Full Text] [Related]

  • 19. Fibrinogen breakdown, long-lasting systemic fibrinolysis, and procoagulant activation during alteplase double-bolus regimen in acute myocardial infarction.
    Stangl K, Laule M, Tenckhoff B, Stangl V, Gliech V, Dübel P, Grohmann A, Melzer C, Langel J, Wernecke KD, Baumann G, Ziemer S.
    Am J Cardiol; 1998 Apr 01; 81(7):841-7. PubMed ID: 9555772
    [Abstract] [Full Text] [Related]

  • 20. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG, Nguyen KT, Soundar E, Kostousov V, Bomgaars L, Moise A, Hui SK, Teruya J.
    Pediatr Crit Care Med; 2014 Jun 01; 15(5):e198-205. PubMed ID: 24614609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.